We are live on ! Find out more
JSMC

Jess S. Morgan & Co Portfolio holdings

AUM $115M
1-Year Est. Return 16.65%
This Fund
S&P 500
This Quarter Est. Return
+0.44%
1 Year Est. Return
-16.65%
3 Year Est. Return
+69.29%
5 Year Est. Return
10 Year Est. Return
AUM
$115M
AUM Growth
+$18.5M
Cap. Flow
+$16.4M
Cap. Flow %
14.24%
Top 10 Hldgs %
47.01%
Holding
39
New
2
Increased
27
Reduced
6
Closed
3

Sector Composition

Rank Sector Weight
1 Healthcare 23.17%
2 Technology 11.66%
3 Consumer Staples 4.02%
4 Industrials 2.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPXU icon
1
ProShares UltraPro Short S&P 500
SPXU
$472M
$12.1M 10.52%
+26,964
New +$9.24M
QQQ icon
2
Invesco QQQ Trust
QQQ
$466B
$5.46M 4.75%
20,430
+2,364
+13% +$713K
SQQQ icon
3
ProShares UltraPro Short QQQ
SQQQ
$2.36B
$5.21M 4.53%
+3,398
New +$3.88M
DBC icon
4
Invesco DB Commodity Index Tracking Fund
DBC
$1.67B
$4.91M 4.27%
205,426
-3,852
-2% -$97.8K
UNH icon
5
UnitedHealth
UNH
$387B
$4.75M 4.14%
9,416
+102
+1% +$53.6K
FTGC icon
6
First Trust Global Tactical Commodity Strategy Fund
FTGC
$2.91B
$4.58M 3.99%
180,899
-3,947
-2% -$104K
AAPL icon
7
Apple
AAPL
$4.9T
$4.56M 3.96%
32,968
+566
+2% +$88.8K
PEP icon
8
PepsiCo
PEP
$187B
$4.31M 3.75%
26,408
+565
+2% +$97.4K
JNJ icon
9
Johnson & Johnson
JNJ
$609B
$4.14M 3.6%
25,327
+415
+2% +$70.2K
XBI icon
10
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$4.01M 3.49%
50,523
+477
+1% +$40.2K
NVCR icon
11
NovoCure
NVCR
$1.84B
$3.73M 3.25%
49,090
+745
+2% +$58.1K
XLP icon
12
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.6B
$3.73M 3.24%
55,844
+42,221
+310% +$3.09M
INTU icon
13
Intuit
INTU
$79.6B
$3.68M 3.2%
9,508
+896
+10% +$387K
AVGO icon
14
Broadcom
AVGO
$1.76T
$3.67M 3.19%
82,610
+20,800
+34% +$1.06M
AXSM icon
15
Axsome Therapeutics
AXSM
$11.8B
$3.52M 3.06%
78,895
-25,994
-25% -$1.3M
TMO icon
16
Thermo Fisher Scientific
TMO
$198B
$3.47M 3.02%
6,850
+89
+1% +$49.8K
IYJ icon
17
iShares US Industrials ETF
IYJ
$1.96B
$3.37M 2.93%
40,264
+112
+0.3% +$10.5K
VCR icon
18
Vanguard Consumer Discretionary ETF
VCR
$6.15B
$3.37M 2.93%
14,343
+19
+0.1% +$4.91K
IEO icon
19
iShares US Oil & Gas Exploration & Production ETF
IEO
$565M
$3.26M 2.84%
39,190
+206
+0.5% +$17.5K
HON icon
20
Honeywell
HON
$71.3B
$3.25M 2.83%
20,671
+265
+1% +$46.2K
SOXX icon
21
iShares Semiconductor ETF
SOXX
$43.4B
$3.07M 2.67%
28,911
+399
+1% +$50K
PPA icon
22
Invesco Aerospace & Defense ETF
PPA
$7.95B
$2.84M 2.47%
43,979
+1,584
+4% +$113K
AGEN
23
Agenus
AGEN
$209M
$2.67M 2.32%
66,338
-836
-1% -$42.6K
FDN icon
24
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.06B
$2.58M 2.24%
20,416
+142
+0.7% +$19.8K
ORMP icon
25
Oramed Pharmaceuticals
ORMP
$165M
$2.37M 2.07%
366,401
+51,100
+16% +$414K

Similar funds

Jess S. Morgan & Co's Q3 2022 Portfolio in Review

As of Q3 2022, Jess S. Morgan & Co held 39 positions worth $115M, up 19% from $96.4M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Jess S. Morgan & Co deployed $16.4M of net new capital in Q3 2022, opening 2 new positions and adding to 27 existing holdings. Its largest new stake was ProShares UltraPro Short S&P 500: 26,964 shares worth $12.1M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Axsome Therapeutics, an estimated $1.3M trimmed.

  • Jess S. Morgan & Co's largest Q3 2022 buy was ProShares UltraPro Short S&P 500: 26,964 shares worth $12.1M.
  • Jess S. Morgan & Co added most to State Street Consumer Staples Select Sector SPDR ETF in Q3 2022, an estimated $3.09M increase.
  • Jess S. Morgan & Co's biggest Q3 2022 reduction was Axsome Therapeutics, cutting an estimated $1.3M.
  • Jess S. Morgan & Co fully exited Adobe in Q3 2022, selling an estimated $2.95M.
  • Jess S. Morgan & Co's ten largest holdings make up 47% of its $115M portfolio in Q3 2022.
  • Jess S. Morgan & Co opened 2 new positions and closed 3 in Q3 2022.
  • Jess S. Morgan & Co's portfolio value rose 19% quarter-over-quarter to $115M.

Based on Jess S. Morgan & Co's 13F filing for Q3 2022, filed 21 Oct 2022.